Analysis of Measles Vaccination Coverage (MCV2) in Lao PDR
Note
This report was generated using AI under general human direction. At the time of generation, the contents have not been comprehensively reviewed by a human analyst.
library(tidyverse)
── Attaching core tidyverse packages ──────────────────────── tidyverse 2.0.0 ──
✔ dplyr 1.2.1 ✔ readr 2.2.0
✔ forcats 1.0.1 ✔ stringr 1.6.0
✔ ggplot2 4.0.4 ✔ tibble 3.3.1
✔ lubridate 1.9.5 ✔ tidyr 1.3.2
✔ purrr 1.2.2
── Conflicts ────────────────────────────────────────── tidyverse_conflicts() ──
✖ dplyr::filter() masks stats::filter()
✖ dplyr::lag() masks stats::lag()
ℹ Use the conflicted package (<http://conflicted.r-lib.org/>) to force all conflicts to become errors
# Loading the processed MCV2 data for Lao PDRmcv2_data <-read_csv("data/MCV2-lao.csv")
New names:
Rows: 24 Columns: 16
── Column specification
──────────────────────────────────────────────────────── Delimiter: "," chr
(6): source, id, indicator, location, iso3, location_name dbl (4): ...1, year,
value, value_num lgl (6): low, high, series, dim1, dim2, dim3
ℹ Use `spec()` to retrieve the full column specification for this data. ℹ
Specify the column types or set `show_col_types = FALSE` to quiet this message.
• `` -> `...1`
Introduction
This report provides an analysis of the Measles-containing-vaccine second dose (MCV2) vaccination coverage in Lao PDR from 2000 to 2023. The data was sourced from the Global Health Observatory (GHO).
Trends in Vaccination Coverage
The dataset contains 24 observations. We examine the temporal trend of the vaccination coverage value.
Data Coverage: The dataset covers the period from 2000 to 2023.
Vaccination Trends: Initially, the reported coverage was 0% until several years into the observation period.
Latest Data: There is a clear upward trend in the reported coverage percentage in recent years, reaching a maximum of 69%.
Conclusion
The vaccination coverage for MCV2 in Lao PDR shows a positive growth trajectory over the observed period. Further investigation into the factors contributing to the increase in vaccination coverage since 2000 is recommended.